February 14, 2018 / 7:02 PM / 6 months ago

BRIEF-U.S. FDA Says Permitted Marketing Of First Blood Test To Evaluate Mild Traumatic Brain Injury, Or Concussion, In Adults

Feb 14 (Reuters) - U.S. Food and Drug Administration:

* U.S. FOOD AND DRUG ADMINISTRATION SAYS PERMITTED MARKETING OF THE FIRST BLOOD TEST TO EVALUATE MILD TRAUMATIC BRAIN INJURY, OR CONCUSSION, IN ADULTS

* U.S. FDA SAYS IS PERMITTING MARKETING OF BRAIN TRAUMA INDICATOR TO BANYAN BIOMARKERS INC Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below